Condition: Clonal Hematopoiesis · CCUS Clonal Cytopenia of Undetermined Significance · Hematologic Disease and Disorders · Sponsor: Clinical Hub for Interventional Research (CHOIR)
People identified to have CH or thought to have possible CH due to unexplained low blood cell counts, including low red blood cells, white blood cells, or platelets will be asked to take part in the study. Individuals who are confirmed to have CH and provide informed consent to participate in the study will have monitoring of their CH, assessment of the risk of heart diseases, blood cancers and personalised support. The researchers will also measure people's understanding of CH and how they feel after learning about CH. Researchers will then record the relevant information from people with CH in a central database over time to track long-term health outcomes. The information collected from the study will help create a blueprint for doctors to provide care for people with CH in the future, and guide further research into CH in Australia. Participants will be asked to donate blood samples for the study for research purposes including CH monitoring and testing and also provide health information for the central database.
This description comes directly from the study's public registry record.
Mark Polizzotto Professor · +61000000000 · mosaic.jcsmr@anu.edu.au
Jun Yen Ng Dr · mosaic.jcsmr@anu.edu.au
Always discuss trial participation with your own doctor first.
| Canberra Health Services | Canberra, Australian Capital Territory, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07313059